Drug Database
Back to search

France· FR:68718936

VIREAD 33 mg/g, granulés

A tenofovir disoproxil product containing fumarate de ténofovir disoproxil, registered in France by GILEAD SCIENCES IRELAND UC (IRLANDE), on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC J05AF07

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedVIREAD 33 mg/g, granulésATCJ05AF07REGISTER NO.FR:68718936PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fumarate de ténofovir disoproxilAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tenofovir disoproxil is registered in 15 of 19 countries.

Countries holding a registration under ATC J05AF07 (tenofovir disoproxil), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose
Search tenofovir disoproxil products by name

Tenofovir disoproxil · ATC J05AF07

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tenofovir disoproxil costs, country by country.

Normalised to the WHO defined daily dose (0.245 g), the median price runs from $0.24 in United States to $14.17 in Switzerland — a ×59 gap.

  • France: $4.15 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Tenofovir disoproxil · price per daily dose (0.245 g)

USD · FX 28 Sept 2026

  • CH Switzerland$14.17
  • FR France$4.15
  • US United States$0.24 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
FUMARATE DE TÉNOFOVIR DISOPROXIL
Manufacturer
GILEAD SCIENCES IRELAND UC (IRLANDE)
Country
France (FR)
ATC code
J05AF07
ATC class
Tenofovir disoproxil
Defined daily dose
0.245 g, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400926789183
    flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 60 g
    EUR 77.74

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

4 interactions on record for tenofovir disoproxil.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tenofovir disoproxil against other medicinesHow interaction checks work

Tenofovir disoproxil · interactions on record

4 records

4 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Tenofovir disoproxil in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tenofovir disoproxil products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Tenofovir Disoproxil Accordpharma, Tenofovir Ratiopharm
  • Bulgaria · Тенофовир Зентива, Тенофовир Полфарма
  • Cyprus · Tenoviral
  • Czechia · Tenofovir Disoproxil Accordpharma, Tenofovir Disoproxil Sandoz
  • Germany · Tenofovirdisoproxil Accord, Tenofovirdisoproxil Al
  • Denmark · Tenofovir Disoproxil Accordpharma, Tenofovir Disoproxil Glenmark
  • Estonia · Tenofovir Disoproxil Sandoz
  • Spain · Tenofovir Disoproxilo Accordpharma, Tenofovir Disoproxilo Aurovitas
  • Finland · Tenofovir Disoproxil Hexal, Tenofovir Disoproxil Sandoz
  • United Kingdom (Northern Ireland) · Tenofovir Disoproxil, Tenofovir Disoproxil Accordpharma
  • Greece · Agardon, Tenofovir Disoproxil Accord Pharma
  • Croatia · Teynofor
  • Hungary · Tenofovir Disoproxil Accordpharma, Tenofovir Onkogen
  • Ireland · Tenofovir Disoproxil Accordpharma, Tenofovir Disoproxil Teva
  • Iceland · Tenofovir Disoproxil Viatris, Tenofovir Disoproxil Zentiva
  • Italy · Tenofovir Disoproxil Aurobindo, Tenofovir Disoproxil Doc Generici
  • Liechtenstein · Tenofovir Disoproxil Viatris, Tenofovir Disoproxil Zentiva
  • Latvia · Tenofovir Disoproxil Teva
  • Netherlands · Tenofovir Disoproxil Accord, Tenofovir Disoproxil Accordpharma
  • Norway · Filmdrasjerte Tabletter Viatris, Tenofovir Disoproxil Accordpharma
  • Poland · Tenofovir Disoproxil Accordpharma, Tenofovir Disoproxil Aurovitas
  • Portugal · Tenofovir Accord, Tenofovir Aurobindo
  • Romania · Tenofovir Disoproxil Accord, Tenofovir Disoproxil Accordpharma
  • Sweden · Tenofovir Disoproxil Accordpharma, Tenofovir Disoproxil Glenmark

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cee9b7da-5dfd-4744-9be2-373bef86abc9
GET /v1/drugs/cee9b7da-5dfd-4744-9be2-373bef86abc9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68718936",
  "date_amm": "2012-11-22",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/01/200",
  "substance": "FUMARATE DE TÉNOFOVIR DISOPROXIL",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "granulés enrobé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about tenofovir disoproxil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console